Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 45 (RPS2P45) is a human processed pseudogene, most likely originating from retrotransposition of the mRNA from the functional RPS2 gene, which encodes a protein of the 40S ribosomal subunit. RPS2P45 does not produce a functional protein, typically contains disablements like frameshifts or premature stop codons, and may show sequence homology to RPS2. While some pseudogenes are transcribed and may generate regulatory noncoding RNAs, there is no reported functional or disease relevance for RPS2P45. The classification as a pseudogene is supported by genomic and evolutionary analysis, indicating that such elements are primarily remnants of gene duplication and retrotransposition events.
Not applicable; pseudogenes do not encode functional protein or receptor targets for drug action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 45 (RPS2P45).